Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0005759 | mitochondrial matrix | 5 | 11 |
GO:0031974 | membrane-enclosed lumen | 2 | 11 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 11 |
GO:0070013 | intracellular organelle lumen | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
Related structures:
AlphaFold database: Q4Q8F2
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006631 | fatty acid metabolic process | 4 | 2 |
GO:0006635 | fatty acid beta-oxidation | 6 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009062 | fatty acid catabolic process | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016042 | lipid catabolic process | 4 | 2 |
GO:0016054 | organic acid catabolic process | 4 | 2 |
GO:0019395 | fatty acid oxidation | 5 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0030258 | lipid modification | 4 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 7 | 2 |
GO:0034440 | lipid oxidation | 5 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044242 | cellular lipid catabolic process | 4 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044282 | small molecule catabolic process | 3 | 2 |
GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 11 |
GO:0003824 | catalytic activity | 1 | 11 |
GO:0005488 | binding | 1 | 11 |
GO:0009055 | electron transfer activity | 3 | 11 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0036094 | small molecule binding | 2 | 11 |
GO:0043167 | ion binding | 2 | 11 |
GO:0043168 | anion binding | 3 | 11 |
GO:0050660 | flavin adenine dinucleotide binding | 4 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901265 | nucleoside phosphate binding | 3 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.224 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.496 |
DOC_CDC14_PxL_1 | 309 | 317 | PF14671 | 0.311 |
DOC_CYCLIN_yCln2_LP_2 | 226 | 232 | PF00134 | 0.436 |
DOC_MAPK_gen_1 | 58 | 67 | PF00069 | 0.461 |
DOC_MAPK_MEF2A_6 | 36 | 44 | PF00069 | 0.451 |
DOC_MAPK_MEF2A_6 | 60 | 69 | PF00069 | 0.428 |
DOC_PIKK_1 | 218 | 226 | PF02985 | 0.477 |
DOC_PP2B_LxvP_1 | 226 | 229 | PF13499 | 0.394 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.436 |
DOC_USP7_MATH_1 | 45 | 49 | PF00917 | 0.451 |
DOC_USP7_MATH_1 | 99 | 103 | PF00917 | 0.436 |
DOC_USP7_UBL2_3 | 147 | 151 | PF12436 | 0.477 |
DOC_WW_Pin1_4 | 177 | 182 | PF00397 | 0.519 |
DOC_WW_Pin1_4 | 21 | 26 | PF00397 | 0.519 |
LIG_14-3-3_CanoR_1 | 115 | 122 | PF00244 | 0.428 |
LIG_14-3-3_CanoR_1 | 135 | 139 | PF00244 | 0.416 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.452 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.428 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.594 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.499 |
LIG_FHA_1 | 235 | 241 | PF00498 | 0.436 |
LIG_FHA_1 | 314 | 320 | PF00498 | 0.331 |
LIG_FHA_2 | 158 | 164 | PF00498 | 0.418 |
LIG_FHA_2 | 288 | 294 | PF00498 | 0.405 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.492 |
LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.424 |
LIG_LIR_Nem_3 | 293 | 299 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 307 | 312 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 79 | 84 | PF02991 | 0.436 |
LIG_MAD2 | 221 | 229 | PF02301 | 0.383 |
LIG_SH2_CRK | 154 | 158 | PF00017 | 0.477 |
LIG_SH2_CRK | 81 | 85 | PF00017 | 0.436 |
LIG_SH2_NCK_1 | 94 | 98 | PF00017 | 0.437 |
LIG_SH2_STAP1 | 94 | 98 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 245 | 248 | PF00017 | 0.436 |
LIG_SH2_STAT5 | 264 | 267 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 94 | 97 | PF00017 | 0.452 |
LIG_SUMO_SIM_par_1 | 64 | 71 | PF11976 | 0.451 |
LIG_TRAF2_1 | 290 | 293 | PF00917 | 0.472 |
LIG_TYR_ITIM | 152 | 157 | PF00017 | 0.477 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.486 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.423 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.418 |
MOD_CK2_1 | 287 | 293 | PF00069 | 0.465 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.428 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.224 |
MOD_GlcNHglycan | 170 | 173 | PF01048 | 0.269 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.326 |
MOD_GlcNHglycan | 269 | 272 | PF01048 | 0.238 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.251 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.258 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.616 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.425 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.423 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.528 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.483 |
MOD_NEK2_1 | 157 | 162 | PF00069 | 0.466 |
MOD_NEK2_1 | 279 | 284 | PF00069 | 0.491 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.481 |
MOD_NEK2_2 | 142 | 147 | PF00069 | 0.477 |
MOD_PK_1 | 58 | 64 | PF00069 | 0.512 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.428 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.416 |
MOD_PKA_2 | 157 | 163 | PF00069 | 0.430 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.465 |
MOD_Plk_1 | 129 | 135 | PF00069 | 0.429 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.412 |
MOD_Plk_4 | 203 | 209 | PF00069 | 0.477 |
MOD_Plk_4 | 61 | 67 | PF00069 | 0.428 |
MOD_ProDKin_1 | 177 | 183 | PF00069 | 0.519 |
MOD_ProDKin_1 | 21 | 27 | PF00069 | 0.519 |
MOD_SUMO_for_1 | 49 | 52 | PF00179 | 0.451 |
TRG_DiLeu_LyEn_5 | 80 | 85 | PF01217 | 0.477 |
TRG_ENDOCYTIC_2 | 154 | 157 | PF00928 | 0.477 |
TRG_ENDOCYTIC_2 | 81 | 84 | PF00928 | 0.436 |
TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.436 |
TRG_Pf-PMV_PEXEL_1 | 221 | 225 | PF00026 | 0.277 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVZ5 | Leptomonas seymouri | 78% | 100% |
A0A0S4II76 | Bodo saltans | 65% | 100% |
A0A1X0NYC9 | Trypanosomatidae | 67% | 100% |
A0A3S5H7J1 | Leishmania donovani | 96% | 100% |
A0A422N351 | Trypanosoma rangeli | 64% | 100% |
A2XNR6 | Oryza sativa subsp. indica | 48% | 91% |
A4HGF9 | Leishmania braziliensis | 86% | 100% |
A4I3J0 | Leishmania infantum | 97% | 100% |
D0A7V3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 57% | 100% |
E9AZT2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
G3KIM6 | Anaerotignum propionicum | 35% | 89% |
H6LBB1 | Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1) | 28% | 78% |
H6LGM8 | Acetobacterium woodii (strain ATCC 29683 / DSM 1030 / JCM 2381 / KCTC 1655 / WB1) | 37% | 82% |
O33096 | Mycobacterium leprae (strain TN) | 37% | 100% |
O85692 | Megasphaera elsdenii | 34% | 96% |
P09819 | Rhizobium meliloti (strain 1021) | 30% | 92% |
P0CN60 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 44% | 94% |
P0CN61 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 44% | 94% |
P13803 | Rattus norvegicus | 52% | 98% |
P13804 | Homo sapiens | 52% | 98% |
P38974 | Paracoccus denitrificans | 52% | 100% |
P52039 | Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) | 37% | 97% |
P53573 | Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) | 49% | 100% |
P53578 | Clostridium saccharobutylicum | 36% | 97% |
P71153 | Thermoanaerobacterium thermosaccharolyticum (strain ATCC 7956 / DSM 571 / NCIMB 9385 / NCA 3814 / NCTC 13789 / WDCM 00135 / 2032) | 39% | 98% |
P78790 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 42% | 95% |
P94551 | Bacillus subtilis (strain 168) | 36% | 100% |
P9WNG8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 37% | 100% |
P9WNG9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 37% | 100% |
Q12480 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 41% | 94% |
Q2KJE4 | Bos taurus | 52% | 98% |
Q46907 | Escherichia coli (strain K12) | 31% | 100% |
Q54FD7 | Dictyostelium discoideum | 48% | 92% |
Q5RC31 | Pongo abelii | 52% | 98% |
Q5Y223 | Cryptococcus gattii serotype B (strain WM276 / ATCC MYA-4071) | 46% | 94% |
Q75LJ3 | Oryza sativa subsp. japonica | 48% | 91% |
Q8HXY0 | Macaca fascicularis | 51% | 98% |
Q8J112 | Cryptococcus neoformans var. grubii | 45% | 94% |
Q93615 | Caenorhabditis elegans | 52% | 98% |
Q99LC5 | Mus musculus | 52% | 98% |
Q9C6I6 | Arabidopsis thaliana | 43% | 90% |
Q9HZP7 | Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) | 52% | 100% |